Post-marketing safety evaluation and objective benefit-risk assessment of sublingual immunotherapy tablets in allergic rhinitis.

Oralair (grass pollen allergen extract) - Stallergenes

Grazax (timothy grass pollen allergen extract tablet) - ALK-Abello

Ragwitek (ragweed allergy vaccine sublingual tablet) - ALK-Abello

Odactra (house dust mite allergy vaccine tablet) - ALK-Abello

http://www.ncbi.nlm.nih.gov/pubmed/41949599

Eleonora Castellana; Maria Rachele Chiappetta

Apr 9, 2026